BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1199 related articles for article (PubMed ID: 19050975)

  • 21. The potential role of TGFbeta1, TGFbeta2 and TGFbeta3 protein expression in colorectal carcinomas. Correlation with classic histopathologic factors and patient survival.
    Tsamandas AC; Kardamakis D; Ravazoula P; Zolota V; Salakou S; Tepetes K; Kalogeropoulou C; Tsota I; Kourelis T; Makatsoris T; Karavias D; Scopa CD; Bonikos DS; Kalofonos HP; Petsas T
    Strahlenther Onkol; 2004 Apr; 180(4):201-8. PubMed ID: 15057430
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Vascular endothelial growth factors C and D represent novel prognostic markers in colorectal carcinoma using quantitative image analysis.
    Hu WG; Li JW; Feng B; Beveridge M; Yue F; Lu AG; Ma JJ; Wang ML; Guo Y; Jin XL; Zheng MH
    Eur Surg Res; 2007; 39(4):229-38. PubMed ID: 17446709
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical significance of Smac/DIABLO expression in colorectal cancer.
    Endo K; Kohnoe S; Watanabe A; Tashiro H; Sakata H; Morita M; Kakeji Y; Maehara Y
    Oncol Rep; 2009 Feb; 21(2):351-5. PubMed ID: 19148507
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Galectin-3 expression is a potent prognostic marker in colorectal cancer.
    Endo K; Kohnoe S; Tsujita E; Watanabe A; Nakashima H; Baba H; Maehara Y
    Anticancer Res; 2005; 25(4):3117-21. PubMed ID: 16080575
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Overexpression of GRP78 and GRP94 are markers for aggressive behavior and poor prognosis in gastric carcinomas.
    Zheng HC; Takahashi H; Li XH; Hara T; Masuda S; Guan YF; Takano Y
    Hum Pathol; 2008 Jul; 39(7):1042-9. PubMed ID: 18482745
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Paradoxical expression of maspin in gastric carcinomas: correlation with carcinogenesis and progression.
    Yu M; Zheng H; Tsuneyama K; Takahashi H; Nomoto K; Xu H; Takano Y
    Hum Pathol; 2007 Aug; 38(8):1248-55. PubMed ID: 17490717
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Urokinase-type plasminogen activator in colorectal cancer: relationship with clinicopathological features and patient outcome.
    Skelly MM; Troy A; Duffy MJ; Mulcahy HE; Duggan C; Connell TG; O'Donoghue DP; Sheahan K
    Clin Cancer Res; 1997 Oct; 3(10):1837-40. PubMed ID: 9815571
    [TBL] [Abstract][Full Text] [Related]  

  • 28. P53 and EGFR expression in colorectal cancer: a reappraisal of 'old' tissue markers in patients with long follow-up.
    Theodoropoulos GE; Karafoka E; Papailiou JG; Stamopoulos P; Zambirinis CP; Bramis K; Panoussopoulos SG; Leandros E; Bramis J
    Anticancer Res; 2009 Feb; 29(2):785-91. PubMed ID: 19331236
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Low levels of insulin-like growth factor type 1 receptor expression at cancer cell membrane predict liver metastasis in Dukes' C human colorectal cancers.
    Nakamura M; Miyamoto S; Maeda H; Zhang SC; Sangai T; Ishii G; Hasebe T; Endoh Y; Saito N; Asaka M; Ochiai A
    Clin Cancer Res; 2004 Dec; 10(24):8434-41. PubMed ID: 15623623
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Reduced p16 expression correlates with lymphatic invasion in colorectal cancers.
    Tada T; Watanabe T; Kazama S; Kanazawa T; Hata K; Komuro Y; Nagawa H
    Hepatogastroenterology; 2003; 50(54):1756-60. PubMed ID: 14696398
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Loss of SIRT1 histone deacetylase expression associates with tumour progression in colorectal adenocarcinoma.
    Jang SH; Min KW; Paik SS; Jang KS
    J Clin Pathol; 2012 Aug; 65(8):735-9. PubMed ID: 22554968
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Interplay of insulin-like growth factor-II, insulin-like growth factor-I, insulin-like growth factor-I receptor, COX-2, and matrix metalloproteinase-7, play key roles in the early stage of colorectal carcinogenesis.
    Nosho K; Yamamoto H; Taniguchi H; Adachi Y; Yoshida Y; Arimura Y; Endo T; Hinoda Y; Imai K
    Clin Cancer Res; 2004 Dec; 10(23):7950-7. PubMed ID: 15585629
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Maspin expression was involved in colorectal adenoma-adenocarcinoma sequence and liver metastasis of tumors.
    Zheng H; Tsuneyama K; Cheng C; Takahashi H; Cui Z; Murai Y; Nomoto K; Takano Y
    Anticancer Res; 2007; 27(1A):259-65. PubMed ID: 17352241
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Multimarker phenotype predicts adverse survival in patients with lymph node-negative colorectal cancer.
    Zlobec I; Minoo P; Baumhoer D; Baker K; Terracciano L; Jass JR; Lugli A
    Cancer; 2008 Feb; 112(3):495-502. PubMed ID: 18076013
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Association of ets-related transcriptional factor E1AF expression with tumour progression and overexpression of MMP-1 and matrilysin in human colorectal cancer.
    Horiuchi S; Yamamoto H; Min Y; Adachi Y; Itoh F; Imai K
    J Pathol; 2003 Aug; 200(5):568-76. PubMed ID: 12898592
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Lactate dehydrogenase 5 expression in operable colorectal cancer: strong association with survival and activated vascular endothelial growth factor pathway--a report of the Tumour Angiogenesis Research Group.
    Koukourakis MI; Giatromanolaki A; Sivridis E; Gatter KC; Harris AL;
    J Clin Oncol; 2006 Sep; 24(26):4301-8. PubMed ID: 16896001
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Lymphatic microvessel density is an independent prognostic factor in colorectal cancer.
    Matsumoto K; Nakayama Y; Inoue Y; Minagawa N; Katsuki T; Shibao K; Tsurudome Y; Hirata K; Nagata N; Itoh H
    Dis Colon Rectum; 2007 Mar; 50(3):308-14. PubMed ID: 17164964
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Curative resection of T1 colorectal carcinoma: risk of lymph node metastasis and long-term prognosis.
    Wang HS; Liang WY; Lin TC; Chen WS; Jiang JK; Yang SH; Chang SC; Lin JK
    Dis Colon Rectum; 2005 Jun; 48(6):1182-92. PubMed ID: 15793641
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Activation of STAT3 is a marker of poor prognosis in human colorectal cancer.
    Kusaba T; Nakayama T; Yamazumi K; Yakata Y; Yoshizaki A; Inoue K; Nagayasu T; Sekine I
    Oncol Rep; 2006 Jun; 15(6):1445-51. PubMed ID: 16685378
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prognostic significance of tumor necrosis factor receptor in colorectal adenocarcinoma.
    Yoshimura H; Dhar DK; Nakamoto T; Kotoh T; Takano M; Soma G; Nagasue N
    Anticancer Res; 2003; 23(1A):85-9. PubMed ID: 12680198
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 60.